Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.64 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.56 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.56 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.55 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | IDE | P14735 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10277136 | 1.00 | TDP1 (0.64) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL13049575 | 1.00 | TDP1 (0.64) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL4904852 | 1.00 | TDP1 (0.64) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL26490546 | 1.00 | TDP1 (0.64) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL15482071 | 1.00 | TDP1 (0.64) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL4740816 | 0.99 | TDP1 (0.65) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL20711508 | 0.97 | TDP1 (0.62) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL20042594 | 0.97 | TDP1 (0.62) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL30735993 | 0.96 | TDP1 (0.61) | TDP1PLCD1F2PRSS1PRSS2 | |
| SCHEMBL31135784 | 0.96 | TDP1 (0.61) | TDP1PLCD1F2PRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190844-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | RIBON THERAPEUTICS, INC. | 2024-06-13 | — | — | US | disclosed |
| US-20240034728-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | RIBON THERAPEUTICS, INC. | 2024-02-01 | — | — | US | disclosed |
| EP-4234551-A2 | PYRIDAZINONES AS PARP7 INHIBITORS | Ribon Therapeutics Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| US-11691969-B2 | Pyridazinones as PARP7 inhibtors | RIBON THERAPEUTICS, INC. (US) | 2023-07-04 | — | — | US | disclosed |
| US-20230192664-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2023-06-22 | — | — | US | disclosed |
| EP-3788040-B1 | PYRIDAZINONES AS PARP7 INHIBITORS | RIBON THERAPEUTICS INC (US) | 2023-04-12 | — | — | EP | disclosed |
| US-11566020-B1 | Pyridazinones as PARP7 inhibitors | RIBON THERAPEUTICS, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220206008-A1 | SCREENING METHODS FOR PARP MODULATORS | ABBVIE BIOTECHNOLOGY LTD (BM) | 2022-06-30 | — | — | US | disclosed |
| US-20220162196-A1 | SOLID FORMS OF A PARP7 INHIBITOR | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2022-05-26 | — | — | US | disclosed |
| US-11014913-B2 | Pyridazinones as PARP7 inhibitors | RIBON THERAPEUTICS, INC. (US) | 2021-05-25 | — | — | US | disclosed |
| CN-112424188-A | Pyridazinones as PARP7 inhibitors | 里邦医疗公司 | 2021-02-26 | — | — | CN | disclosed |
| US-20210024502-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2021-01-28 | — | — | US | disclosed |
| US-10870641-B2 | Pyridazinones as PARP7 inhibitors | RIBON THERAPEUTICS, INC. (US) | 2020-12-22 | — | — | US | disclosed |
| US-20200123134-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2020-04-23 | — | — | US | disclosed |
| US-10550105-B2 | Pyridazinones as PARP7 inhibitors | Ribon Therapeutics Inc. (US) | 2020-02-04 | — | — | US | disclosed |
| US-20190331688-A1 | SCREENING METHODS FOR PARP MODULATORS | ABBVIE BIOTECHNOLOGY LTD (BM) | 2019-10-31 | — | — | US | disclosed |
| US-20190330194-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2019-10-31 | — | — | US | disclosed |
| US-9089605-B2 | Quinone derivatives, pharmaceutical compositions, and uses thereof | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-07-28 | — | — | US | disclosed |
| US-20090247420-A1 | METHOD FOR ENCODING AND SCREENING COMBINATORIAL LIBRARIES | NATIONAL SCIENCE FOUNDATION | 2009-10-01 | — | — | US | disclosed |
| US-6232089-B1 | INHIBITED BY (4-(N-HYDROXYAMINO)-2-ISOBUTYL-3-(2-THIOPHENEMETHYL)-SUCCINYL) -PHENYLALANINE-N-METHYL AMIDE AND 1,10-PHENANTHROLINE | SMITHKLINE BEECHAM CORPORATION | 2001-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024502-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-20220206008-A1 | SCREENING METHODS FOR PARP MODULATORS | PARP1, PARP2, PARP3 | TDP1 30/4885PLCD1 1810/4885F2 3947/4885 |
| US-20220162196-A1 | SOLID FORMS OF A PARP7 INHIBITOR | PARP1, PARP2, PARP4 | TDP1 92/4885PLCD1 2070/4885F2 2694/4885 |
| US-20240190844-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-10550105-B2 | Pyridazinones as PARP7 inhibitors | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-20190330194-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-20190331688-A1 | SCREENING METHODS FOR PARP MODULATORS | PARP1, PARP2, PARP3 | TDP1 30/4885PLCD1 1810/4885F2 3947/4885 |
| US-11014913-B2 | Pyridazinones as PARP7 inhibitors | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-11566020-B1 | Pyridazinones as PARP7 inhibitors | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-10870641-B2 | Pyridazinones as PARP7 inhibitors | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-11691969-B2 | Pyridazinones as PARP7 inhibtors | PARP2, PARP1, PARP4 | TDP1 216/4885PLCD1 2360/4885F2 2190/4885 |
| US-20230192664-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-20200123134-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
| US-20240034728-A1 | PYRIDAZINONES AS PARP7 INHIBITORS | PARP2, PARP1, PARP4 | TDP1 223/4885PLCD1 2306/4885F2 3041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.